WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s FARXIGA ® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 ...
Maryland’s Prescription Drug Affordability Board says it has identified two diabetes drugs that could be made more affordable for residents based on a cost study by the state agency. During a meeting ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
Following the FDA’s September announcement of a crackdown on direct-to-consumer drug marketing practices and the subsequent flurry of untitled and warning letters criticizing dozens of Big Pharma ads, ...
(NEW YORK) — AstraZeneca’s diabetes drug, Farxiga, has become the first in its class to receive FDA approval as a treatment for heart failure. “It’s great news for patients with this condition,” said ...
(Reuters) - AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration has granted fast track status for the development of its diabetes drug Farxiga to prevent heart and kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback